These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

930 related items for PubMed ID: 15940674

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L.
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [Abstract] [Full Text] [Related]

  • 3. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E, Escamochero S, Cabañas R, Díaz R, Fiandor A, Bellón T.
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L, Villard J, de Rham C, Degermann S, Chapuis B, Huard B, Roosnek E.
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus.
    Sáez-Borderías A, Gumá M, Angulo A, Bellosillo B, Pende D, López-Botet M.
    Eur J Immunol; 2006 Dec; 36(12):3198-206. PubMed ID: 17109473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H, Wauquier N, Cherfils-Vicini J, Cremer I, Debré P, Vieillard V.
    AIDS; 2008 Jan 11; 22(2):217-26. PubMed ID: 18097224
    [Abstract] [Full Text] [Related]

  • 10. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2006 Jun 11; 70(1-2):33-42. PubMed ID: 16488482
    [Abstract] [Full Text] [Related]

  • 11. Expression of NK cell receptors on decidual T cells in human pregnancy.
    Tilburgs T, van der Mast BJ, Nagtzaam NM, Roelen DL, Scherjon SA, Claas FH.
    J Reprod Immunol; 2009 Jun 11; 80(1-2):22-32. PubMed ID: 19394706
    [Abstract] [Full Text] [Related]

  • 12. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun 11; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 13. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ, Melero I, Navarro F, Carretero M, Bellón T, Llano M, Colonna M, Geraghty DE, López-Botet M.
    J Immunol; 1997 Jun 15; 158(12):5736-43. PubMed ID: 9190923
    [Abstract] [Full Text] [Related]

  • 14. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J, Park JS, Nam JH, Bang D, Sohn S, Lee ES, Park KS.
    Tissue Antigens; 2007 Oct 15; 70(4):307-13. PubMed ID: 17767552
    [Abstract] [Full Text] [Related]

  • 15. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells.
    Lafarge X, Pitard V, Ravet S, Roumanes D, Halary F, Dromer C, Vivier E, Paul P, Moreau JF, Déchanet-Merville J.
    Eur J Immunol; 2005 Jun 15; 35(6):1896-905. PubMed ID: 15864777
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M, Greimers R, de Valensart N, Nayjib B, Tasken K, Boniver J, Moutschen M, Rahmouni S.
    Biochem Pharmacol; 2005 Sep 01; 70(5):714-24. PubMed ID: 15978547
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Triggering of effector functions on a CD8+ T cell clone upon the aggregation of an activatory CD94/kp39 heterodimer.
    Bellón T, Heredia AB, Llano M, Minguela A, Rodriguez A, López-Botet M, Aparicio P.
    J Immunol; 1999 Apr 01; 162(7):3996-4002. PubMed ID: 10201920
    [Abstract] [Full Text] [Related]

  • 20. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.
    Eur J Immunol; 1997 Aug 01; 27(8):1875-80. PubMed ID: 9295021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.